This $1,887,583 Cooperative Agreement award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support the Washington University Advancing Cancer Control Equity Research through Transformative Solutions Center (WASHU-ACCERT). The center's goal is to advance cancer control equity through community-engaged, multilevel research interventions that address the impact of social determinants of health on adverse cancer control outcomes. Key activities include:
Engaging a diverse team of cancer health equity investigators and building capacity among academic and community partners
Developing a shared resource to support the implementation and dissemination of rigorous internal and cross-center projects
Identifying opportunities and plans to effectively address social determinants of health and reduce cancer disparities
The center will also provide a $250,364 sub-award to the Missouri Center for Public Health Excellence, whose executive director will serve as a community principal investigator and chair the community advisory board. This subrecipient will help facilitate connections to public health and cancer control activities across Missouri and Illinois. The award period runs from August 2024 through July 2029.